Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Novel roles of Fc gamma binding protein in colonic host-microbiota interactions

Award Number: R21AI186312
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2025
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

Novel roles of Fc gamma binding protein in colonic host-microbiota interactions - PROJECT SUMMARY/ABSTRACT The Fc fragment of IgG binding protein (Fc gamma binding protein, FCGBP) is a prominent component of the mucus layer that lines the epithelium of the large intestine. Reduced levels of FCGBP are present in the structurally-weaken colon mucus layer that is characteristic of ulcerative colitis (UC). In addition, either low expression or deficiency due to genetically mutated FCGBP is associated with lower disease-free survival of patients with colorectal cancer (CRC). Normally, the abundance of FCGBP in the colon mucus layer is similar to that of mucin 2 (MUC2), the major secreted mucin in the colon. However, unlike MUC2, the functions of FCGBP are not well understood. In fact, a number of previously described functions of FCGBP, including the IgG interaction from which the name derives, have been subsequently disputed. We posit that the abundance of FCGBP in the barrier-protective colon mucus layer, coupled with the well-established association with diseases of the colon, warrant an improved and definitive understanding of the functions of this protein in health and disease. We have utilized mice with partial or complete loss of Fcgbp to begin to understand the functions of Fcgbp at homeostasis and during inflammation. Our studies suggest previously unknown but essential contributions to the structure of the colon mucus layer and to the composition of the mucus-associated microbiota. Fcgbp deficiency also appears to trigger major compensatory pathways, which potentially underlie the connection between low levels of FCGBP and susceptibility to colon inflammation and cancer. Therefore, in this exploratory proposal, we will determine the contribution of Fcgbp to the overall glycosylation and terminal sialylation of the colon mucus layer and determine how this affects the abundance of specific bacteria in the mucus layer. In addition, we will explore immune pathways that are deployed to limit spontaneous inflammation when expression of Fcgbp is suppressed and determine the possible connections to disease susceptibility. If successful, our studies will define novel functions for Fcgbp in intestinal immune homeostasis and identify key mechanisms whereby reduced Fcgbp impacts disease susceptibility in the large intestine.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $185,625 )
2026	2026	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	2	4/28/2026	NON-COMPETING CONTINUATION	$185,625
														Subtotal = $185,625

Issue Date FY: 2025 ( Subtotal = $222,750 )
2025	2025	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Allergy and Infectious Diseases Research	000	1	4/28/2025	NEW	$222,750
														Subtotal = $222,750

Grand Total All Awards = $408,375

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Novel roles of Fc gamma binding protein in colonic host-microbiota interactions

Award Number: R21AI186312

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2025

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer